NCT00001320View on ClinicalTrials.gov

Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients

CompletedOBSERVATIONAL
Enrollment

265

Participants

Timeline

Start Date

October 31, 1991

Study Completion Date

July 31, 2003

Conditions
HealthySchizophrenia
Trial Locations (1)

20892

National Institute of Mental Health (NIMH), Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00001320 - Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients | Biotech Hunter | Biotech Hunter